Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation

Anatomical differences between the renal cortex and medulla may influence inflammatory responses. Owing to the difficulty in diagnosing rejections from the medulla, rejection is usually diagnosed through the cortex. However, previous studies have shown that there are no significant differences in re...

Full description

Bibliographic Details
Main Authors: A Young Kim, Kyu Hyang Cho, Jong Won Park, Jun Young Do, Man-Hoon Han, Yong-Jin Kim, Seok Hui Kang
Format: Article
Language:English
Published: Korean Society for Transplantation 2021-03-01
Series:Korean Journal of Transplantation
Subjects:
Online Access:http://journaleditor.inforang.com/journal/view.html?doi=10.4285/kjt.20.0047
_version_ 1827365372310847488
author A Young Kim
Kyu Hyang Cho
Jong Won Park
Jun Young Do
Man-Hoon Han
Yong-Jin Kim
Seok Hui Kang
author_facet A Young Kim
Kyu Hyang Cho
Jong Won Park
Jun Young Do
Man-Hoon Han
Yong-Jin Kim
Seok Hui Kang
author_sort A Young Kim
collection DOAJ
description Anatomical differences between the renal cortex and medulla may influence inflammatory responses. Owing to the difficulty in diagnosing rejections from the medulla, rejection is usually diagnosed through the cortex. However, previous studies have shown that there are no significant differences in renal cortical and medullary lesions in acute allograft rejection. A 60-year-old man with a history of diabetic nephropathy underwent kidney transplant from a living unrelated donor at our hospital in August 2019. Three days after surgery, his urine output suddenly decreased, whereas the serum creatinine levels increased. A kidney biopsy showed only medullary lesions with positive C4d-staining and a Banff score of PTC grade 3. He was diagnosed with acute antibody-mediated rejection (AMR) and treatment was initiated. He did not respond to conventional treatments, including plasma exchange and intravenous immunoglobulin, but his general condition improved after bortezomib administration. There have been a few cases of acute AMR limited to medullary lesions. We consider that rejection cannot be excluded even if the lesions are confined to the medulla.
first_indexed 2024-03-08T08:27:23Z
format Article
id doaj.art-5df68352cb3746da98eb3d2bff2528b1
institution Directory Open Access Journal
issn 2671-8790
language English
last_indexed 2024-03-08T08:27:23Z
publishDate 2021-03-01
publisher Korean Society for Transplantation
record_format Article
series Korean Journal of Transplantation
spelling doaj.art-5df68352cb3746da98eb3d2bff2528b12024-02-02T04:20:12ZengKorean Society for TransplantationKorean Journal of Transplantation2671-87902021-03-01351535810.4285/kjt.20.0047kjt.20.0047Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantationA Young Kim0Kyu Hyang Cho1Jong Won Park2Jun Young Do3Man-Hoon Han4Yong-Jin Kim5Seok Hui Kang6Division of Nephrology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, KoreaDivision of Nephrology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, KoreaDivision of Nephrology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, KoreaDivision of Nephrology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, KoreaDepartment of Pathology, School of Medicine, Kyungpook National University, Daegu, KoreaDepartment of Pathology, School of Medicine, Kyungpook National University, Daegu, KoreaDivision of Nephrology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, KoreaAnatomical differences between the renal cortex and medulla may influence inflammatory responses. Owing to the difficulty in diagnosing rejections from the medulla, rejection is usually diagnosed through the cortex. However, previous studies have shown that there are no significant differences in renal cortical and medullary lesions in acute allograft rejection. A 60-year-old man with a history of diabetic nephropathy underwent kidney transplant from a living unrelated donor at our hospital in August 2019. Three days after surgery, his urine output suddenly decreased, whereas the serum creatinine levels increased. A kidney biopsy showed only medullary lesions with positive C4d-staining and a Banff score of PTC grade 3. He was diagnosed with acute antibody-mediated rejection (AMR) and treatment was initiated. He did not respond to conventional treatments, including plasma exchange and intravenous immunoglobulin, but his general condition improved after bortezomib administration. There have been a few cases of acute AMR limited to medullary lesions. We consider that rejection cannot be excluded even if the lesions are confined to the medulla.http://journaleditor.inforang.com/journal/view.html?doi=10.4285/kjt.20.0047kidney transplantation; rejection; bortezomib; medullary lesion
spellingShingle A Young Kim
Kyu Hyang Cho
Jong Won Park
Jun Young Do
Man-Hoon Han
Yong-Jin Kim
Seok Hui Kang
Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation
Korean Journal of Transplantation
kidney transplantation; rejection; bortezomib; medullary lesion
title Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation
title_full Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation
title_fullStr Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation
title_full_unstemmed Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation
title_short Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation
title_sort acute antibody mediated rejection limited to medullary lesions in following abo incompatible living donor kidney transplantation
topic kidney transplantation; rejection; bortezomib; medullary lesion
url http://journaleditor.inforang.com/journal/view.html?doi=10.4285/kjt.20.0047
work_keys_str_mv AT ayoungkim acuteantibodymediatedrejectionlimitedtomedullarylesionsinfollowingaboincompatiblelivingdonorkidneytransplantation
AT kyuhyangcho acuteantibodymediatedrejectionlimitedtomedullarylesionsinfollowingaboincompatiblelivingdonorkidneytransplantation
AT jongwonpark acuteantibodymediatedrejectionlimitedtomedullarylesionsinfollowingaboincompatiblelivingdonorkidneytransplantation
AT junyoungdo acuteantibodymediatedrejectionlimitedtomedullarylesionsinfollowingaboincompatiblelivingdonorkidneytransplantation
AT manhoonhan acuteantibodymediatedrejectionlimitedtomedullarylesionsinfollowingaboincompatiblelivingdonorkidneytransplantation
AT yongjinkim acuteantibodymediatedrejectionlimitedtomedullarylesionsinfollowingaboincompatiblelivingdonorkidneytransplantation
AT seokhuikang acuteantibodymediatedrejectionlimitedtomedullarylesionsinfollowingaboincompatiblelivingdonorkidneytransplantation